Efficacy and Safety of 3- and 5-Injection Patterns (30 and 50 U) of Botulinum Toxin A (Dysport) for the Treatment of Wrinkles in the Glabella and the Central Forehead Region
Authors:
- Berthold RzanyBRBerthold Rzany
- Benjamin AscherBABenjamin Ascher
- Alina FratilaAFAlina Fratila
- Gary D. MonheitGMGary D. Monheit
- Sergio TalaricoSTSergio Talarico
- Wolfram SterryWSWolfram Sterry
Open Access
- 1 March 2006
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 142 (3) , 320-326
Abstract
Botulinum toxin A has been used successfully for esthetic purposes for almost 2 decades, although only a few clinical trials supporting its use have been published so far,1-3 and most of the evidence is in the form of case series. Dysport (Ipsen Pharma, Ettlingen, Germany), the brand of botulinum toxin A used in this study, has been available for more than a decade in Europe and is registered for various neurological indications. The product has been used “off label” in dermatology,4-8 a field in which there is considerable practical experience with its cosmetic use but few controlled trials reporting its efficacy and safety to date.Keywords
This publication has 6 references indexed in Scilit:
- Clinical comparability of marketed formulations of botulinum toxinMovement Disorders, 2004
- Relevant anatomy for botulinum toxin facial rejuvenationFacial Plastic Surgery Clinics of North America, 2003
- Reproducibility of a four-point clinical severity score for glabellar frown linesBritish Journal of Dermatology, 2003
- A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar linesJournal of the American Academy of Dermatology, 2002
- Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patientsBritish Journal of Dermatology, 2001
- Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating)New England Journal of Medicine, 2001